A mathematical model to estimate the effect of different antiretroviral scale-up scenarios suggests that rapid scale-up is critical if universal access is to be achieved during the next 5 years for all people in need of treatment.
During the past 5 years, substantial progress has been made in South Africa to expand care and treatment for HIV-infected individuals. However, only about 30% of people with AIDS in South Africa are currently receiving antiretroviral therapy (ART). How quickly would ART programs need to be scaled up there in order for all ART-eligible patients to have access to treatment by 2012?
Researchers developed a simulation model to project the effects of five potential scale-up scenarios in South Africa: zero growth (no new treatment slots are created), constant growth (a fixed number of new treatment slots is created each year), moderate growth (an increasing number of new treatment slots is created each year), rapid scale-up (the number of new trea…
Reviewing Author
DisclosuresConsultant/Advisory BoardUNAIDS; WHO; Bill and Melinda Gates Foundation, Population Council
Grant/Research SupportNIH; National Institute of Allergy and Infectious Diseases; Tides Foundation/MAC AIDS Fund; USAID; South African National Research Foundation; European Union; South African Medical Research Council
Editorial BoardsNew England Journal of Medicine; AIDS Reviews; AIDS Research and Human Retroviruses; mBio; Indian Journal of Medical Research; JAIDS: Journal of Acquired Immune Deficiency Syndromes
DisclosuresConsultant/Advisory BoardUNAIDS; WHO; Bill and Melinda Gates Foundation, Population Council
Grant/Research SupportNIH; National Institute of Allergy and Infectious Diseases; Tides Foundation/MAC AIDS Fund; USAID; South African National Research Foundation; European Union; South African Medical Research Council
Editorial BoardsNew England Journal of Medicine; AIDS Reviews; AIDS Research and Human Retroviruses; mBio; Indian Journal of Medical Research; JAIDS: Journal of Acquired Immune Deficiency Syndromes